What assessment should the nurse prioritize when monitoring African American patients taking methylprednisolone?

When monitoring African American patients taking methylprednisolone, prioritizing the measurement of the patient's blood glucose frequently is crucial. Methylprednisolone is a corticosteroid that can lead to hyperglycemia due to its impact on glucose metabolism. These patients may be at a higher risk for developing elevated blood sugar levels, especially if they have pre-existing conditions such as diabetes or insulin resistance, which can be more prevalent in this demographic.

Monitoring blood glucose allows for early detection and management of hyperglycemia, which can prevent further complications such as increased thirst, frequent urination, and even more serious conditions like ketoacidosis if glucose levels remain uncontrolled. Frequent assessments are vital to ensure that any rise in blood sugar can be addressed promptly, thereby maintaining the patient's overall health and well-being while on corticosteroid therapy. This proactive approach to managing a known side effect emphasizes the importance of individualized patient care in the context of specific demographics and their responses to medication.